• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Model Number SGC0301
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Atrial Perforation (2511)
Event Date 08/14/2020
Event Type  Injury  
Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The clip delivery system device is filed under a separate medwatch report.
 
Event Description
This is filed to report the atrial septal defect.It was reported that the patient presented in critical condition with right heart failure, dilated left atrium and mitral regurgitation.Prior to the mitraclip procedure, the patient had been hospitalized for two weeks and was expected to continue with a prolonged hospitalization post mitraclip procedure.The mitraclip procedure was performed to treat mixed mitral regurgitation (mr) with a grade of 4+.First, an ntw clip was implanted.A second clip delivery system (cds) was advanced and placed on the leaflets; however, when closing the clip to perform leaflet insertion, the patient¿s heart rate increased, blood pressure dropped, ekg changes were noted, and the patient went into cardiogenic shock.Cardioversion was performed, a balloon pump was inserted, and the patient stabilized.The cds and was removed without deploying the clip.Mr was reduced to 3.Per the physician, the patient did not tolerate the mitraclip procedure very well due to their presenting critical condition.After removal of the mitraclip system, the atrial septal defect (asd) was closed with a closure device.Post procedure, the patient was stabilized in improved condition.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have influenced the reported issues.The reported patient effect of atrial septal defect requiring intervention as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.Based on the available information, the reported atrial perforation was due to a combination of challenging anatomy and procedural conditions.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10491894
MDR Text Key205713165
Report Number2024168-2020-07388
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648216824
UDI-Public08717648216824
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/11/2021
Device Model NumberSGC0301
Device Catalogue NumberSGC0301
Device Lot Number00212U104
Was Device Available for Evaluation? No
Date Manufacturer Received09/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
IMPLANTED MITRACLIP(X1); STEERABLE GUIDE CATHETER
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient Weight94
-
-